Delivery Order SPE2DB22D3016-SPE2DB24FATK6
Award Date 4/23/24
Potential Completion Date 5/14/24
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, awarded by the Defense Logistics Agency (DLA), is a delivery order to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of VEKLURY 100 MG VIALS, a pharmaceutical product, with a ceiling value of $13,618.40 and a completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- This federal contract award, valued at $13,618.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of VEKLURY 100 MG VIALS. The contract is a delivery order with a firm fixed-price pricing structure and an ultimate completion date of August 19, 2024. Amerisourcebergen, through its Corporate Office Division, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by various...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,566.90, is for the supply of VEKLURY 100 MG VIALS, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of January 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $27,236.80, is for the supply of VEKLURY 100 mg vials, a critical pharmaceutical product. This order is placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of VEKLURY 100 MG VIALS. The award is a Firm Fixed Price Delivery Order with a ceiling value of $15,848.80 and a period of performance ending on July 1, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $27,236.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VEKLURY 100 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This federal contract award is for the delivery of VEKLURY 100 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $15,848.80. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 17, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides comprehensive global...
- The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $13,618.40 Firm Fixed Price delivery order contract is for the supply of VEKLURY 100 MG vials, a critical pharmaceutical product. This award is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive range of medical commodities in...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The delivery order, valued at $6,809.20, is for the supply of VEKLURY 100 MG VIALS, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,817.84 for the provision of VEKLURY 100 MG VIALS, a critical pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FATK6Delivery Order
This federal contract award, with a ceiling value of $13,618.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of VEKLURY 100 MG VIALS, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 7/23/24, 10:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 4/23/24 |